Fennec Pharmaceuticals (TSX:FRX) FCF Yield % : -6.78 (As of Apr. 28, 2024)

View and export this data going back to 2001. Start your Free Trial

What is Fennec Pharmaceuticals FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Fennec Pharmaceuticals's Trailing 12-Month Free Cash Flow is C$-23.13 Mil, and Market Cap is C$340.92 Mil. Therefore, Fennec Pharmaceuticals's FCF Yield % for today is -6.78%.

The historical rank and industry rank for Fennec Pharmaceuticals's FCF Yield % or its related term are showing as below:

TSX:FRX' s FCF Yield % Range Over the Past 10 Years
Min: -13.09 Med: -8.59 Max: -5.08
Current: -6.78

During the past 13 years, the highest FCF Yield % of Fennec Pharmaceuticals was -5.08%. The lowest was -13.09%. And the median was -8.59%.

TSX:FRX's FCF Yield % is ranked better than
66.13% of 1550 companies
in the Biotechnology industry
Industry Median: -15.535 vs TSX:FRX: -6.78

Fennec Pharmaceuticals's FCF Margin % for the quarter that ended in Dec. 2023 was -49.92%.

Fennec Pharmaceuticals FCF Yield % Historical Data

The historical data trend for Fennec Pharmaceuticals's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fennec Pharmaceuticals FCF Yield % Chart

Fennec Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-7.10

-8.45

-12.50

-7.11

-5.61

Fennec Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Yield %	Get a 7-Day Free Trial															-10.71	-10.51	-6.37	-5.59	-6.37

Competitive Comparison of Fennec Pharmaceuticals's FCF Yield %

For the Biotechnology subindustry, Fennec Pharmaceuticals's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fennec Pharmaceuticals's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Fennec Pharmaceuticals's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Fennec Pharmaceuticals's FCF Yield % falls into.

Fennec Pharmaceuticals FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Fennec Pharmaceuticals's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-22.999	/	409.72932
	=	-5.61%

Fennec Pharmaceuticals's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-6.52	*	4	/	409.72932
	=	-6.37%

Fennec Pharmaceuticals FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Fennec Pharmaceuticals FCF Yield % Related Terms

Thank you for viewing the detailed overview of Fennec Pharmaceuticals's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Fennec Pharmaceuticals (TSX:FRX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fennec Pharmaceuticals Inc (TSX:FRX) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

FENC:USA RV41:Germany

Address

68 TW Alexander Drive, PO Box 13628, Research Triangle Park, NC, USA, 27709

Website

https://www.fennecpharma.com

Fennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is engaged in research and development activities. The company is developing Sodium Thiosulfate (STS), a chemo-protectant against hearing loss associated with platinum-based chemotherapy. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin induced hearing loss, or ototoxicity in children. The company principally operates in the United States.